Brief: Moberg Pharma Q4 EBITDA Above Expectations At SEK 27.0 Million

Moberg Pharma AB (publ)

13/02/2018 07:05

Feb 13 (Reuters) - MOBERG PHARMA AB (PUBL)  MBPH.ST : 
    * Q4 NET REVENUE SEK 90.1 MILLION (89.4) 
    * Q4 EBITDA SEK 27.0 MILLION (12.0) 
    * Q4 OPERATING PROFIT (EBIT) SEK 17.6 MILLION (7.1) 
    * Q4 EBITDA SEK 27.0 MILLION (REUTERS POLL: SEK 19.6 
MILLION) 
 
Source text for Eikon:  ID:nWkr134Tj5  
Further company coverage:  MBPH.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))